๐ฐ Wdif News
Page 4 - Wdif News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wdif. Real-time updates on events, politics, business and more.
February 4, 2022
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world Sputnik V has been authorized in 71 countries
January 1, 2022
The Alliance of Digital India Foundation (ADIF) on Saturday hailed the decision by the Competition Commission of India (CCI) to open an anti-trust investigation into Apple over its App Store business practises, saying that tech giants like Apple and Google are choking innovation via their unfair app store rules.
December 23, 2021
Theย RBI hasย extended the card-on-file tokenisation deadline by six months to June 30, 2022, in view of various representations received from industry bodies.
December 21, 2021
- More and more countries are using Sputnik Light as a standalone vaccine and as a universal booster, including against Omicron variant. MOSCOW, Dec. 21, 2021 /PRNewswire/ -- The Russian
December 17, 2021
MOSCOW" Dec. 17, 2021 /PRNewswire/ -- - The Gamaleya Center's recent preliminary laboratory study shows that Sputnik V demonstrates high virus neutralizing activity (VNA) against the Omicron
December 17, 2021
Russian Direct Investment Fund (RDIF) on Friday said that Sputnik V and Sputnik Light vaccines induce robust neutralizing antibody response to COVID-19 variant Omicron.
December 17, 2021
Each vaccine cocktail combination with Sputnik Light provided higher antibody titer on the 14th day after administering a second dose when compared to original homogenous regimens of each of the vaccines RDIF said
December 12, 2021
As the Indian startup/unicorn ecosystem goes through a stupendous growth, a level-playing field must exist for all the participants and stakeholders of the ecosystem and not just desi startups, Sijo Kuruvilla George, executive director of the Alliance of Digital India Foundation (ADIF) said on Sunday.
December 7, 2021
MOSCOW, Dec. 7, 2021 /PRNewswire/ --The European Medicines Agency (EMA) today announced the heterologous vaccination (mix&match) approach (pioneered by the Russian Sputnik vaccine) can be used
December 6, 2021
Results of a separate joint clinical trial of a combination of Sputnik Light with the AstraZeneca vaccine have demonstrated that it induces strong immunity and has a high safety profile